Los Angeles, CA (January 9, 2024) – The Celiac Disease Foundation, a global leader in celiac disease patient advocacy, today announced its Board of Directors re-appointments for 2024. The Board represents a diverse mix of professionals, patients, and caregivers who are deeply committed to advancing the Foundation’s mission of accelerating diagnosis, treatments, and a cure for celiac disease.
The Board of Directors announcement follows the Foundation’s recent addition of three senior-level staff.
“The Celiac Disease Foundation is on a strong growth trajectory, and we are fortunate to have such a dedicated, talented Board of Directors who are a powerful force for continued momentum in research, advocacy, and community support,” said Foundation CEO Marilyn G. Geller.
“With our seasoned Board of Directors and accomplished staff, we look forward to another year of groundbreaking progress. Together, we are committed to championing our mission to elevate awareness and advance transformative initiatives for those living with celiac disease,” said Adrienne Bender, Celiac Disease Foundation Board Chair since 2021.
The 2024 Celiac Disease Foundation Board:
- Adrienne Bender, Board Chair (returning)
- William Thurston, Vice Chair
- Bradley J. Herrema, Secretary (returning)
- Warren Saft, Treasurer
- Lee Jones, Development Chair (returning)
- John Wagner, Advocacy Chair (returning)
- Dan Gibbons
- Casey Guber
- Jordan Ramer
- Jamie Resin
- Yasith Weerasuriya
- Kristin Yarema, PhD
The Foundation also announced Linda Solomon’s retirement from the Board, which she joined in 2016. Solomon was diagnosed with celiac disease in 2015, and shortly thereafter, two of her children were diagnosed. She was inspired to join the Board based on her lived experience and was instrumental in the implementation of the Board’s Development Committee.
Board Directors serve the Foundation for two-year terms with Board Officers serving for one-year terms. Further Celiac Disease Foundation Board of Directors information can be found here.
About the Celiac Disease Foundation
The Celiac Disease Foundation, established in 1990, is a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease. Our mission is to improve the health and well-being of the millions of individuals around the world affected by this genetic autoimmune disease through our strategic investments in research, advocacy, and education. Our iCureCeliac® Patient Registry and extensive patient recruitment services at iRecruitCeliac.org enable us to identify qualified patient candidates and speed their enrollment to advance critical disease research. Our unparalleled advocacy program has led the way to secure federal recognition and first-ever research funding from agencies including the U.S. National Institutes of Health and the Department of Defense. We adhere to the highest scientific and ethical standards as we work each day to promote understanding of celiac disease, empower our patient and provider community, and collaborate with partners and stakeholders to carry our mission forward.